Oklo Clears Regulatory Hurdle for First Commercial Nuclear Reactor. The Stock Rises. -- Barrons.com

Dow Jones
06/11

By Mackenzie Tatananni

Pre-revenue nuclear start-up Oklo has taken another step toward commercializing its technology, clearing a key regulatory hurdle for its upcoming Aurora powerhouse at Idaho National Laboratory.

The stock rose 5.4% in premarket trading Thursday to $56.92.

The Energy Department approval relates to Aurora's preliminary documented safety analysis, a review of the reactor's safety controls, design, and hazard management. CEO Jacob DeWitte described the clearance as an "important milestone" and a foundation for future deployments.

Oklo is one of nearly a dozen companies selected for a federal pilot program in 2025. The initiative is on a tight schedule, aiming to have at least three test reactors running at U.S. national laboratories by the start of next month.

Earlier this week, the Energy Department confirmed that a design from rival Antares Nuclear will be the first of several reactors to go critical by the July 4 deadline.

Aurora is the first of Oklo's planned powerhouses. It will run on recovered fuel from the Experimental Breeder Reactor-II, which was shut down in 1994 following a government policy pivot and subsequent congressional defunding.

Oklo is building its own fuel fabrication site on the grounds of Idaho National Laboratory. The start-up is exploring ways to use plutonium as a temporary "bridge fuel" while the U.S. builds out domestic supply chains for traditional fuels like high-assay low-enriched uranium.

Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 11, 2026 08:11 ET (12:11 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10